165
Views
71
CrossRef citations to date
0
Altmetric
Original Article

Interleukin-10 in Non-Hodgkin's Lymphoma

&
Pages 251-259 | Received 20 Sep 1996, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Meriem Rabia Zahzeh, Bouchra Loukidi, Warda Meziane, Mustapha Haddouche, Naima Mesli, Zahia Zouaoui & Mourad Aribi. (2015) Relationship between NADPH and Th1/Th2 ratio in patients with non-Hodgkin lymphoma who have been exposed to pesticides. Journal of Blood Medicine 6, pages 99-107.
Read now
G. Muti$suffix/text()$suffix/text(), V. Mancini, E. Ravelli & E. Morra. (2005) Significance of Epstein-Barr virus (EBV) load and Interleukin-10 in post-transplant lymphoproliferative disorders. Leukemia & Lymphoma 46:10, pages 1397-1407.
Read now
Anna E. Kossakowska, Stefan J. Urbanski & Anna Janowska-Wieczorek. (2000) Matrix Metalloproteinases and Their Tissue Inhibitors - Expression, Role and Regulation in Human Malignant Non-Hodgkin's Lymphomas. Leukemia & Lymphoma 39:5-6, pages 485-493.
Read now

Articles from other publishers (68)

Chenhui Bao, Jiayan Gu, Xin Huang, Liangshun You, Ziyang Zhou & Jie Jin. (2023) Cytokine profiles in patients with newly diagnosed diffuse large B-cell lymphoma: IL-6 and IL-10 levels are associated with adverse clinical features and poor outcomes. Cytokine 169, pages 156289.
Crossref
Dong-Na Yang, Li-Ming Zhong & Feng-Qiong Huang. (2023) Clinical effect of standardized nursing for lymphoma patients and the influencing factors of nosocomial infection. Medicine 102:3, pages e32624.
Crossref
Narendranath Epperla, Walter Hanel & Moshe Talpaz. 2017. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine 1 21 .
MarwaAhmed Gamaleldin, MayadaAly Moussa & SalmaAlaa Eldin Imbaby. (2022) Role of interleukin-10 (1082G/A) and splicing factor 3B subunit 1 (2098A/G) gene polymorphisms in chronic lymphocytic leukemia. Journal of Applied Hematology 13:2, pages 76.
Crossref
Marcus Bauer, Simon Jasinski-Bergner, Ofer Mandelboim, Claudia Wickenhauser & Barbara Seliger. (2021) Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies. Cancers 13:20, pages 5189.
Crossref
Laura E. Martínez, Tracy R. Daniels-Wells, Yu Guo, Larry I. Magpantay, Pierre V. Candelaria, Manuel L. Penichet, Otoniel Martínez-Maza & Marta Epeldegui. (2021) Targeting TfR1 with the ch128.1/IgG1 Antibody Inhibits EBV-driven Lymphomagenesis in Immunosuppressed Mice Bearing EBV+ Human Primary B-cells. Molecular Cancer Therapeutics 20:9, pages 1592-1602.
Crossref
Kyle P. D’mello, Lei Zhao, Erin C. Kaser, Ziwen Zhu, Huaping Xiao, Mark R. Wakefield, Qian Bai & Yujiang Fang. (2021) The role of interleukins and the widely studied TNF-α in non-Hodgkin’s lymphoma. Medical Oncology 38:5.
Crossref
Maria Teresa Gonzalez-Garza, Delia Elva Cruz-Vega & Carmen Maldonado-Bernal. 2021. Translational Research in Cancer. Translational Research in Cancer.
Alexandra Ladouceur, Hiromi Tissera, Ann E. Clarke, Rosalind Ramsey-Goldman, Caroline Gordon, James E. Hansen & Sasha Bernatsky. 2021. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus 461 467 .
Shaghayegh Khanmohammadi, Mahsima Shabani, Mohammadreza Tabary, Elham Rayzan & Nima Rezaei. (2020) Lymphoma in the setting of autoimmune diseases: A review of association and mechanisms. Critical Reviews in Oncology/Hematology 150, pages 102945.
Crossref
Li Gao, Haige Han, Honglei Wang, Li Cao & Wen-hai Feng. (2019) IL-10 knockdown with siRNA enhances the efficacy of Doxorubicin chemotherapy in EBV-positive tumors by inducing lytic cycle via PI3K/p38 MAPK/NF-kB pathway. Cancer Letters 462, pages 12-22.
Crossref
Leila Sawada, Yoshiko Nagano, Atsuhiko Hasegawa, Hikari Kanai, Kai Nogami, Sayaka Ito, Tomoo Sato, Yoshihisa Yamano, Yuetsu Tanaka, Takao Masuda & Mari Kannagi. (2017) IL-10-mediated signals act as a switch for lymphoproliferation in Human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways. PLOS Pathogens 13:9, pages e1006597.
Crossref
Ravi Maddaly, Aishwarya Subramaniyan & Harini Balasubramanian. (2017) Cancer Cytokines and the Relevance of 3D Cultures for Studying Those Implicated in Human Cancers. Journal of Cellular Biochemistry 118:9, pages 2544-2558.
Crossref
Maria Cosenza, Monica Civallero, Luigi Marcheselli, Stefano Sacchi & Samantha Pozzi. (2017) Ricolinostat, a selective HDAC6 inhibitor, shows anti-lymphoma cell activity alone and in combination with bendamustine. Apoptosis 22:6, pages 827-840.
Crossref
Suhendan Ekmekcioglu & Elizabeth A. Grimm. 2016. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine 1 17 .
Renu Verma, Lavanya Balakrishnan, Kusum Sharma, Aafaque Ahmad Khan, Jayshree Advani, Harsha Gowda, Srikanth Prasad Tripathy, Mrutyunjay Suar, Akhilesh Pandey, Sheetal Gandotra, T. S. Keshava Prasad & Subramanian Shankar. (2015) A network map of Interleukin-10 signaling pathway. Journal of Cell Communication and Signaling 10:1, pages 61-67.
Crossref
Hiromi Tissera, Ann E. Clarke, Rosalind Ramsey Goldman, Caroline Gordon, James E. Hansen & Sasha Bernatsky. 2016. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus 411 415 .
V. A. Ovsepyan, A. Kh. Gabdulkhakova, A. A. Shubenkiva & E. N. Zotina. (2015) Role of Interleukin-10 Gene Promoter Region Polymorphism in the Development of Chronic Lymphoid Leukemia. Bulletin of Experimental Biology and Medicine 160:2, pages 275-277.
Crossref
Holly L. Geyer, Amylou C. Dueck, Robyn M. Scherber & Ruben A. Mesa. (2015) Impact of Inflammation on Myeloproliferative Neoplasm Symptom Development. Mediators of Inflammation 2015, pages 1-9.
Crossref
Suhendan Ekmekcioglu, Razelle Kurzrock & Elizabeth A. Grimm. 2015. The Molecular Basis of Cancer. The Molecular Basis of Cancer 789 808.e4 .
Rosalind Ramsey-Goldman, Sasha Bernatsky & Ann Clarke. (2014) Dialogue: what can we learn about the relationship between systemic lupus erythematosus and haematological malignancies from linking disease registries?. Lupus Science & Medicine 1:1, pages e000068.
Crossref
Kerstin L. Edlefsen, Otoniel Martínez-Maza, Margaret M. Madeleine, Larry Magpantay, Dana K. Mirick, Kenneth J. Kopecky, Andrea Z. LaCroix & Anneclaire J. De Roos. (2014) Cytokines in serum in relation to future non-Hodgkin lymphoma risk: Evidence for associations by histologic subtype. International Journal of Cancer 135:4, pages 913-922.
Crossref
Jingsheng Tuo, Defen Shen, Howard Hua Yang & Chi-Chao Chan. (2014) Distinct MicroRNA-155 Expression in the Vitreous of Patients With Primary Vitreoretinal Lymphoma and Uveitis. American Journal of Ophthalmology 157:3, pages 728-734.
Crossref
Ryan Incrocci, Molly McCormack & Michelle Swanson-Mungerson. (2013) Epstein–Barr virus LMP2A increases IL-10 production in mitogen-stimulated primary B-cells and B-cell lymphomas. Journal of General Virology 94:5, pages 1127-1133.
Crossref
Christina Heemann, Markus Kreuz, Irene Stoller, Nils Schoof, Frederike von Bonin, Marita Ziepert, Markus Löffler, Wolfram Jung, Michael Pfreundschuh, Lorenz Trümper & Dieter Kube. (2012) Circulating Levels of TNF Receptor II Are Prognostic for Patients with Peripheral T-cell Non–Hodgkin Lymphoma. Clinical Cancer Research 18:13, pages 3637-3647.
Crossref
Paul M. Barr, Chungwen Wei, James Roger, Julia Schaefer-Cutillo, Jennifer L. Kelly, Alexander F. Rosenberg, John Jung, I?aki Sanz & Jonathan W. Friedberg. (2012) Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion. Clinical Immunology 142:3, pages 237-242.
Crossref
Xiaoguang Cao, Defen Shen, David G. Callanan, Manabu Mochizuki & Chi-Chao Chan. (2011) Diagnosis of systemic metastatic retinal lymphoma. Acta Ophthalmologica 89:2, pages e149-e154.
Crossref
Kamini Singh, Surajit Sinha, Sunil Kumar Malonia, Pradeep Bist, Vinay Tergaonkar & Samit Chattopadhyay. (2009) Tumor Suppressor SMAR1 Represses IκBα Expression and Inhibits p65 Transactivation through Matrix Attachment Regions. Journal of Biological Chemistry 284:2, pages 1267-1278.
Crossref
Antica Duletić-Načinović, Sanja Štifter, Blažen Marijić, Ksenija Lučin, Toni Valković, Duška Petranović & Nives Jonjić. (2018) Serum IL-6, IL-8, IL-10 and Beta 2 -Microglobulin in Association with International Prognostic Index in Diffuse Large B Cell Lymphoma . Tumori Journal 94:4, pages 511-517.
Crossref
J. S. Lee, P. M. Bracci & E. A. Holly. (2008) Non-Hodgkin Lymphoma in Women: Reproductive Factors and Exogenous Hormone Use. American Journal of Epidemiology 168:3, pages 278-288.
Crossref
A. NAČINOVIĆ-DULETIĆ, S. ŠTIFTER, Š. DVORNIK, Ž. ŠKUNCA & NIVES JONJIĆ. (2008) Correlation of serum IL-6, IL-8 and IL-10 levels with clinicopathological features and prognosis in patients with diffuse large B-cell lymphoma. International Journal of Laboratory Hematology 30:3, pages 230-239.
Crossref
Gertraud Maskarinec, Eva Erber, Jasmeet Gill, Wendy Cozen & Laurence N. Kolonel. (2008) Overweight and Obesity at Different Times in Life as Risk Factors for Non-Hodgkin's Lymphoma: The Multiethnic Cohort. Cancer Epidemiology, Biomarkers & Prevention 17:1, pages 196-203.
Crossref
Suhendan Ekmekcioglu, Razelle Kurzrock & Elizabeth A. Grimm. 2008. The Molecular Basis of Cancer. The Molecular Basis of Cancer 605 619 .
Chi-Chao Chan, John A. Gonzales & Ahmed A. Hidayat. 2008. Albert &amp Jakobiec's Principles &amp Practice of Ophthalmology. Albert &amp Jakobiec's Principles &amp Practice of Ophthalmology 1255 1280 .
Dong Hwan Kim. 2009. Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response. Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response 203 229 .
Stacie L. Lambert & Olivia M. Martinez. (2007) Latent Membrane Protein 1 of EBV Activates Phosphatidylinositol 3-Kinase to Induce Production of IL-10. The Journal of Immunology 179:12, pages 8225-8234.
Crossref
Je‐Jung Lee, Dong Hwan Kim, Nan Young Lee, Sang Kyun Sohn, Jong Gwang Kim, Hyeoung‐Joon Kim, Young Rok Do & Yeon Hee Park. (2007) Interleukin‐10 gene polymorphism influences the prognosis of T‐cell non‐Hodgkin lymphomas. British Journal of Haematology 137:4, pages 329-336.
Crossref
Ismail Oguz Kara, Berksoy Sahin & Ramazan Gunesacar. (2007) Expression of soluble CD27 and interleukins-8 and -10 in B-cell chronic lymphocytic leukemia: Correlation with disease stage and prognosis. Advances in Therapy 24:1, pages 29-40.
Crossref
E. Dawn Flick, K. Arnold Chan, Paige M. Bracci & Elizabeth A. Holly. (2006) Use of Nonsteroidal Antiinflammatory Drugs and Non-Hodgkin Lymphoma: A Population-based Case-Control Study. American Journal of Epidemiology 164:5, pages 497-504.
Crossref
Yong Wei & Jessie L.-S. Au. 2005. Integration/Interaction of Oncologic Growth. Integration/Interaction of Oncologic Growth 285 321 .
Behnam Ebrahimi, Susan L. Tucker, Donghui Li, James L. Abbruzzese & Razelle Kurzrock. (2004) Cytokines in pancreatic carcinoma. Cancer 101:12, pages 2727-2736.
Crossref
Nikolaus Becker, Evelin Deeg & Alexandra Nieters. (2004) Population-based study of lymphoma in Germany: rationale, study design and first results. Leukemia Research 28:7, pages 713-724.
Crossref
C HAHN, M AL & J TEW. (2004) Comparison of Type 1 and Type 2 Cytokine Production by Mononuclear Cells Cultured With Streptococcus mutans and Selected Other Caries Bacteria. Journal of Endodontics 30:5, pages 333-338.
Crossref
Thomas Zander, Daniel Re, Michael von Bergwelt-Baildon, Jürgen Wolf & Joachim L. Schultze. 2004. Cancer Immunotherapy at the Crossroads. Cancer Immunotherapy at the Crossroads 295 314 .
K. Asadullah, W. Sterry & H. D. Volk. (2003) Interleukin-10 Therapy—Review of a New Approach. Pharmacological Reviews 55:2, pages 241-269.
Crossref
Segolene Mahot, Alain Sergeant, Emmanuel Drouet & Henri Gruffat. (2003) A novel function for the Epstein–Barr virus transcription factor EB1/Zta: induction of transcription of the hIL-10 gene. Journal of General Virology 84:4, pages 965-974.
Crossref
Sergey V. Sennikov, Sergey V. Krysov, Tatiana V. Injelevskaya, Alexandr N. Silkov, Lyubov V. Grishina & Vladimir A. Kozlov. (2003) Quantitative analysis of human immunoregulatory cytokines by electrochemiluminescence method. Journal of Immunological Methods 275:1-2, pages 81-88.
Crossref
Tatsuharu Ohno, Yasunori Ueda, Ken-ichi Nagai, Takayuki Takahashi, Yoshiteru Konaka, Teruyuki Takamatsu, Takayo Suzuki, Masataka Sasada & Takashi Uchiyama. (2003) The Serum Cytokine Profiles of Lymphoma-associated Hemophagocytic Syndrome: A Comparative Analysis of B-Cell and T-Cell/Natural Killer Cell Lymphomas. International Journal of Hematology 77:3, pages 286-294.
Crossref
Fazil Aydin, Mustafa Yilmaz, Feyyaz Özdemir, Halil Kavgaci, Melek Nur Yavuz & Ali Aydin Yavuz. (2002) Correlation of Serum IL-2, IL-6 and IL-10 Levels With International Prognostic Index in Patients With Aggressive Non-Hodgkin’s Lymphoma. American Journal of Clinical Oncology 25:6, pages 570-572.
Crossref
I Y Rosenblum & A D Dayan. (2016) Carcinogenicity testing of IL-10: principles and practicalities. Human & Experimental Toxicology 21:7, pages 347-358.
Crossref
Annette Boehler. (2002) The role of interleukin-10 in lung transplantation. Transplant Immunology 9:2-4, pages 121-124.
Crossref
R Kurzrock. (2001) Cytokine deregulation in cancer. Biomedicine & Pharmacotherapy 55:9-10, pages 543-547.
Crossref
Razelle Kurzrock. (2001) The role of cytokines in cancer-related fatigue. Cancer 92:S6, pages 1684-1688.
Crossref
Kevin W. MooreRene de Waal MalefytRobert L. CoffmanAnne O'Garra. (2001) Interleukin-10 and the Interleukin-10 Receptor. Annual Review of Immunology 19:1, pages 683-765.
Crossref
Liliana GuedezAdnan MansoorBente Birkedal-HansenMegan S. LimPaula FukushimaDavid VenzonWilliam G. Stetler-StevensonMaryalice Stetler-Stevenson. (2001) Tissue inhibitor of metalloproteinases 1 regulation of interleukin-10 in B-cell differentiation and lymphomagenesis. Blood 97:6, pages 1796-1802.
Crossref
Nozomi NiitsuJunko Okabe-KadoMasataka OkamotoToshiyuki TakagiTakashi YoshidaSadao AokiMasami HiranoYoshio Honma. (2001) Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma. Blood 97:5, pages 1202-1210.
Crossref
C.Stephen Foster & Esen K. Akpek. (2001) Author?s reply. Ophthalmology 108:3, pages 428.
Crossref
Luis FayadMichael J. KeatingJames M. ReubenSusan O'BrienBang-Ning LeeSusan LernerRazelle Kurzrock. (2001) Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome. Blood 97:1, pages 256-263.
Crossref
Alok A. Khorana, Joseph D. Rosenblatt & Faith M. Young. 2001. HIV & HTLV-I Associated Malignancies. HIV & HTLV-I Associated Malignancies 19 74 .
P Vineis. (2000) Delayed infection, family size and malignant lymphomas. Journal of Epidemiology & Community Health 54:12, pages 907-911.
Crossref
M.B. Lappin & J.D.M. Campbell. (2000) The Th1-Th2 classification of cellular immune responses: concepts, current thinking and applications in haematological malignancy. Blood Reviews 14:4, pages 228-239.
Crossref
Deborah K. Duff, Suzanne Thompson, Stephen Braye, David Price, Mark Loewenthal & Michael J. Boyle. (2000) The cytokine milieu of HIV-associated non-Hodgkin's lymphoma favours aggressive tumours. AIDS 14:1, pages 92-94.
Crossref
Michael R. Shurin, Lina Lu, Pawel Kalinski, Ann M. Stewart-Akers & Michael T. Lotze. (1999) Th1/Th2 balance in cancer, transplantation and pregnancy. Springer Seminars in Immunopathology 21:3, pages 339-359.
Crossref
Robert A. Baiocchi & Michael A. Caligiuri. (1999) Cytokines in the evolution and treatment of AIDS-lymphoma. Current Opinion in Oncology 11:6, pages 516.
Crossref
Elli F Kamper, Anastasios D PapahilisS, Maria K Angelopoulou, Ludmila T Kopeikina, Marina P Siakantaris, Gerassimos A Pangalis & John C Stavrudis. (1999) Serum levels of tetranectin, intercellular adhesion molecule-1 and interleukin-10 in B-chronic lymphocytic leukemia. Clinical Biochemistry 32:8, pages 639-645.
Crossref
Anna E. KossakowskaDylan R. EdwardsChristopher PrusinkiewiczMelissa C. ZhangDianlin GuoStefan J. UrbanskiThomas GroganLeah A. MarquezAnna Janowska-Wieczorek. (1999) Interleukin-6 Regulation of Matrix Metalloproteinase (MMP-2 and MMP-9) and Tissue Inhibitor of Metalloproteinase (TIMP-1) Expression in Malignant Non-Hodgkin’s Lymphomas. Blood 94:6, pages 2080-2089.
Crossref
R.M. Beaty, K. Rulli, K.L. Bost, J. Pantginis, J. Lenz & L.S. Levy. (1999) High Levels of IL-4 and IL-10 mRNA and Low Levels of IL-2, IL-9 and IFN-γ mRNA in MuLV-Induced Lymphomas. Virology 261:2, pages 253-262.
Crossref
Sven Arvid Birkeland, Klaus Bendtzen, Bjarne M??ller, Stephen Hamilton-Dutoit & Hans Kerzel Andersen. (1999) INTERLEUKIN-10 AND POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER AFTER KIDNEY TRANSPLANTATION1. Transplantation 67:6, pages 876-881.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.